Check-Cap Ltd
CHEKZ
NASDAQ Capital Market0.01
USD
- -
- -
Check-Cap Ltd
CHEKZ
(NASDAQ Capital Market)
Recent
price
0.01
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Check-Cap Ltd. Check-Cap Ltd. (NASDAQ: CHEK), a clinical-stage medical diagnostics company based in Isfiya, Israel, and founded in 2004 or 2005, develops and advances capsule-based screening technology utilizing ultra-low-dose X-rays to detect precancerous polyps, colorectal cancers, and other structural abnormalities in the colon. The company offers the C-Scan system, comprising the C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, a disposable back-mounted tracking system with biocompatible adhesive patches; and C-Scan View software for data download, analysis, and report generation; this preparation-free, at-home solution targets individuals at average risk for colorectal cancer who avoid traditional invasive screening methods due to discomfort or bowel preparation requirements. Operations are primarily in Israel, with planned commercialization in the United States, Europe, Israel, and Japan; the company conducts ongoing clinical trials for regulatory approvals including from the FDA, while building manufacturing, supply chain, and commercialization infrastructure. In September 2025, Check-Cap Ltd. entered into a definitive merger agreement with MBody AI, a Nevada-based developer of embodied AI for the autonomous workforce, under which MBody AI equityholders would own 90% of the combined entity and Check-Cap shareholders 10%, with Check-Cap's legacy medical diagnostics business, patents, and proprietary equipment continuing as a subsidiary. The merger, approved by 98% of voting shareholders at an extraordinary general meeting in mid-November 2025 including a name change to MBody AI Ltd. or similar, awaits final closing and potential Nasdaq compliance restoration via related financing, while terminating a prior business combination with Apollo Technology Capital Corporation; this strategic shift complements Check-Cap's New Jersey Ghost Kitchen franchise rights and positions the combined company in high-growth AI sectors.